Pfizer

TRUMENBA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Pfizer

Trumenba HCPCS:

90621

HCPCS Code Descriptor:

Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp), 2 or 3 dose schedule, for intramuscular use

Category:

CPT Drug Code

Trumenba NDCs:

00005-0100-05, 00005-0100-10

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Trumenba CPT Codes:

Potential CPT administration codes for Trumenba can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00005-0100-05, 00005-0100-10

About Trumenba:

TRUMENBA is a Immunology drug manufactured by Pfizer and administered via the Intramuscular route of administration. The CPT Drug Code: 90621 is aligned to the drug TRUMENBA.

ACCESS PRICING AND MORE BY REGISTERING

90621 Added Date:

NA

90621 Effective Date:

NA

90621 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Trumenba billing and coding information.
Our team did not identify a source for Trumenba patient assistance information. Please reach out to our team if you feel that this is a mistake.
TRUMENBA prescribing information can be found at the link below:
Information regarding TRUMENBA’s side effects can be found at MedlinePlus